Latest Regulatory Approvals News

Waratah Minerals reports significant new high-grade gold intersections at its Spur Gold Project in New South Wales, extending known mineralisation and accelerating its drilling program with nine rigs active.

Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.

Western Ridge Resources has received regulatory approval to commence drilling at its historic Keystone Project, marking the first major exploration in over eight decades. The fully funded program aims to unlock new high-grade silver extensions and test multiple promising targets.

Premier1 Lithium has completed a high-resolution gravity survey at its Rochefort Gold Prospect, confirming strong structural controls on gold mineralisation and setting the stage for maiden drilling in Q2 2026.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.

Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.

Nickel Industries has secured a significant increase in its 2026 ore sales license and finalized a long-term supply agreement for its Excelsior Nickel Cobalt project, enhancing production certainty and sustainability.

Challenger Limited’s attempt to acquire Pepper Money has been declined by Pepper’s board, while Challenger moves forward with a $150 million share buy-back program.

Forrestania Resources has announced a JORC-compliant Mineral Resource Estimate of 103,500 ounces of gold at its Johnson Range Project, fulfilling a key condition for acquiring Aurumin Johnson Range Pty Ltd and Aurumin Mt Dimer Pty Ltd from Newcam Minerals.

Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.

Native Mineral Resources (ASX: NMR) has updated its drilling results at the Podosky deposit in Queensland, confirming shallow, high-grade gold mineralisation that supports near-term open-pit mining plans. Mining activities are targeted to commence in April 2026.

Avira Resources has validated significant high-grade gold intersections at its Mt Cattlin Gold Project, underpinning plans for a maiden Mineral Resource Estimate by the end of 2026. The company is poised to commence drilling in Q2 to test extensions across multiple prospects.